Codes / ICD10CM / H04.039

H04.039 Chronic enlargement of unspecified lacrimal gland

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Chronic enlargement of unspecified lacrimal gland

Summary

Chronic enlargement of the unspecified lacrimal gland refers to a persistent, non-acute increase in the size of the lacrimal gland, which is responsible for tear production. This condition may affect one or both eyes and is characterized by long-term or recurrent symptoms. It is often associated with underlying causes that require ongoing evaluation and management.

Causes

Chronic enlargement of the lacrimal gland can result from persistent inflammatory processes, such as chronic infections (viral or bacterial) or autoimmune conditions like Sjögren's syndrome. In some cases, the enlargement may be idiopathic, meaning no specific cause is identified. Repeated or unresolved acute episodes of inflammation can also contribute to the development of chronic enlargement.

Risk Factors

Individuals with a history of autoimmune disorders, particularly Sjögren's syndrome, are at increased risk. Chronic infections affecting the lacrimal gland or surrounding tissues may predispose to this condition. Prolonged exposure to irritants or unresolved inflammatory processes can also contribute to the risk.

Symptoms

  • Persistent swelling in the outer portion of the upper eyelid.
  • Chronic eyelid redness and tenderness.
  • Ongoing pain or discomfort in the eye region.
  • Changes in tear production, such as increased or decreased tearing.
  • Visual disturbances if the gland enlargement affects nearby structures.

Diagnosis

Diagnosis typically involves a thorough clinical examination, including assessment of eyelid swelling, tenderness, and tear production. Imaging studies, such as ultrasound or MRI, may be used to evaluate the lacrimal gland's size and structure. Laboratory tests, including autoimmune markers, may help identify underlying causes like Sjögren's syndrome. A biopsy may be considered if malignancy is suspected.

Treatment Options

Treatment focuses on addressing the underlying cause and managing symptoms. Anti-inflammatory medications, such as corticosteroids, may reduce swelling and pain. Immunosuppressive agents can be used for autoimmune-related cases. Artificial tears or lubricating ointments may help manage tear production changes. In severe or refractory cases, surgical intervention to remove or reduce the enlarged gland may be necessary.

Prognosis and Follow-Up

The prognosis depends on the underlying cause and response to treatment. Chronic cases may require long-term management to control symptoms and prevent complications. Regular follow-up with an ophthalmologist is recommended to monitor gland size, tear function, and any progression of the condition. Early intervention can improve outcomes and reduce the risk of complications.

Complications

Potential complications include chronic discomfort, vision impairment due to gland enlargement, and secondary infections. In rare cases, untreated or progressive enlargement may lead to more serious conditions, such as lacrimal gland malignancy or permanent damage to tear production.

Lifestyle & Prevention

Avoiding known irritants, such as smoke or allergens, may help reduce symptoms. Maintaining good eye hygiene and using lubricating drops as needed can support tear production. Managing underlying conditions, such as autoimmune disorders, through prescribed treatments can help prevent exacerbations. Regular eye examinations are advised for early detection of changes.

When to Seek Professional Help

Seek medical attention if you experience persistent eyelid swelling, pain, or changes in tear production. Prompt evaluation is important if symptoms worsen or if you notice vision changes, as these may indicate a more serious underlying issue requiring immediate intervention.

Tips for Medical Coders

Use H04.039 for chronic enlargement of the lacrimal gland when the specific side (right or left) is not documented. Ensure documentation supports the chronic nature of the condition, as acute or unspecified cases may require different coding. Verify that no laterality is specified before applying this code.

Book a walkthrough

H04.039 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.